Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Mission Produce Q2 Earnings Call Highlights

Mission Produce (NASDAQ:AVO) said its fiscal second quarter was pressured by an unusually high-supply avocado market, particularly from Mexico, which drove prices to multi-year lows and compressed margins despite higher avocado volumes. President and Chief Executive Officer John Pawlowski, who form

Motorcar Parts of America Q4 Earnings Call Highlights

Motorcar Parts of America (NASDAQ:MPAA) reported stronger fiscal fourth-quarter and full-year results, with management pointing to sales momentum, new business commitments and improving profitability as key drivers heading into fiscal 2027. Chairman, President and Chief Executive Officer Selwyn Jof

3 Stocks With Fresh Catalysts to Watch Before the July 4

3 Stocks With Fresh Catalysts to Watch Before the July 4

Broadcom, Palo Alto Networks, and Planet Labs each reported strong results and offer potential upside as investors position for the second half of 2025.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Amprius Insiders Are Selling: Should Investors Be Worried?

Amprius Technology is on track to set a new all-time high later this year after it reports Q2 results and guidance. Short interest suggests a squeeze is possible.

A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus

A weaker dollar means international revenue can have a bigger impact, and these companies might be positioned to take advantage of an otherwise tough situation.

Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead

Assembly Biosciences (NASDAQ:ASMB) outlined its antiviral and liver disease development strategy during a fireside chat at the 47th Annual Goldman Sachs Healthcare Conference, highlighting upcoming decisions tied to its herpes simplex virus type 2 program, expansion of its hepatitis delta candidate

Graham Q4 Earnings Call Highlights

Graham (NYSE:GHM) reported record fiscal 2026 revenue, orders and backlog, with management pointing to strong demand in defense, improving momentum in space and contributions from recent acquisitions as the company enters fiscal 2027. On the company’s fiscal fourth-quarter earnings call, President

inkl

Read news from The Economist, FT, and more,
with one subscription

A Market Rotation Toward Quality Will Benefit These 3 ETFs

A Market Rotation Toward Quality Will Benefit These 3 ETFs

"Quality" stocks may be better able to withstand market turbulence thanks to stable earnings, strong balance sheets, and more; these ETFs aim to find them.

3 Multi-Metal Stocks for Income and Long-Term Growth

3 Multi-Metal Stocks for Income and Long-Term Growth

These three metals stocks offer exposure to copper, gold, and silver while combining growth potential with income opportunities

Optical Cable Q2 Earnings Call Highlights

Optical Cable (NASDAQ:OCC) reported sharply higher fiscal second-quarter sales and profit, with management citing strength in enterprise, data center and severe-duty markets, as well as improved manufacturing leverage. On the company’s fiscal 2026 second-quarter earnings call, President and Chief E

Nebius Is Up Nearly 175% This Year—Here's What's Driving the Latest Run

Nebius Is Up Nearly 175% This Year—Here's What's Driving the Latest Run

Nebius Group is up 175% year-to-date, driven by an NVIDIA endorsement, a 5.6% hedge fund stake, and 684% year-over-year Q1 revenue growth.

Technology Stocks Just Got Cheaper—Here Are 5 Mega-Caps Worth a Closer Look

Technology Stocks Just Got Cheaper—Here Are 5 Mega-Caps Worth a Closer Look

A major market-wide selloff on Friday compressed valuations across several mega-cap technology stocks, creating potential long-term opportunity.

3 Energy Stocks Built for the AI Power Boom—And Beyond

3 Energy Stocks Built for the AI Power Boom—And Beyond

Marc Lichtenfeld highlights HAL, CVX, and HASI as energy stocks positioned to benefit from AI-driven electricity demand growth forecast at 3.5% annually through 2030.

Duluth Q1 Earnings Call Highlights

Duluth (NASDAQ:DLTH) reported a narrower first-quarter loss and higher gross margins as management said its ongoing effort to reduce promotions, rationalize inventory and cut costs continued to reshape the apparel retailer’s financial profile. President and Chief Executive Officer Stephanie Puglies

Get all your
news in one place.

100's of premium titles.
One news app.

FuelCell Energy Q2 Earnings Call Highlights

FuelCell Energy (NASDAQ:FCEL) reported a wider second-quarter loss for fiscal 2026 as a non-cash impairment tied to its Groton Navy project weighed on results, while management emphasized a sharply expanding sales pipeline tied largely to data center and artificial intelligence-related power demand.

Allstate’s Comeback Is Turning Into a Profit Machine

Allstate profits have surged as underwriting, premiums, and investment income improve, but severe weather remains a key risk for investors.

VinFast Auto Q1 Earnings Call Highlights

VinFast Auto (NASDAQ:VFS) reported sharply higher first-quarter 2026 vehicle deliveries and revenue, while management said gross margin was pressured by accounting impacts tied to an expanded free-charging program and other adjustments. On the company’s earnings call, Chairman Pham Nhat Quan Anh sa

Gamehaus Q3 Earnings Call Highlights

Gamehaus (NASDAQ:GMHS) reported third-quarter fiscal 2026 revenue above its prior guidance range while management emphasized improving profitability, tighter marketing discipline and growing use of direct-to-consumer payments and artificial intelligence across the business. On the company’s earning

Get all your
news in one place.

100's of premium titles.
One news app.

What's Make of Macy's: Berkshire Hathaway's Latest Buy

Berkshire Hathaway just turned over a rock that many would not think to look under. See the status of its latest portfolio addition, retail giant Macy's.

Planet Labs: Coming Back Down to Earth

Planet Labs posted 42% revenue growth and a surging backlog, but after a massive rally investors must weigh execution against valuation

Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win

Compass Therapeutics (NASDAQ:CMPX) Chief Executive Officer Tom Schuetz said the company is preparing for a key U.S. Food and Drug Administration meeting on tovecimig, its DLL4/VEGF bispecific antibody, after a randomized study in advanced biliary tract cancer met its primary endpoint and a key secon

Campbell's Q3 Earnings Call Highlights

Campbell's (NASDAQ:CPB) executives used the company’s third-quarter fiscal 2026 earnings question-and-answer session to outline a more cautious operating backdrop heading into fiscal 2027, citing potential incremental inflation tied to higher oil prices, continued pressure in snacks and a focus on b

AstroNova Q1 Earnings Call Highlights

AstroNova (NASDAQ:ALOT) reported higher fiscal first-quarter revenue and improved profitability, driven primarily by strength in its Aerospace segment, as management said the company is benefiting from commercial aircraft demand, growing orders and internal cost controls. On the company’s fiscal 20

Docusign: Another Beat, Another Selloff—Why the Analysts Are Wrong

DocuSign's earnings selloff looks harsh. IAM momentum, buybacks and low expectations could make this turnaround worth watching.

Meta Unveils Subscriptions: A New Offering With Real Growth Potential

Meta Platforms may be listening to investor complaints on monetization, unveiling several subscription plans to get more out of its huge user base.

1 … 13 14 15 16

People

Leopold Aschenbrenner

Pham Nhat Vuong

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

392,745 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play